MediciNova, Inc.
MNOVNext catalyst
MN-001
Non-alcoholic Steatohepatitis
Get an email about MNOV's next catalysts
Track MediciNova (MNOV) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 2 more upcoming events in our data (earnings, Phase 3 readout).See the timeline
3 upcoming, 0 past
MNOV Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.06 | FQ end Sep/2026 | Call: tbd
MN-001 Phase 2 Est. Readout
Primary completion for MN-001 trial (NCT05464784) in Diabetes Mellitus, Type 2
SourceMN-166 Phase 3 Est. Readout (COMBAT-ALS)
Primary completion for MN-166 trial (NCT04057898) in Amyotrophic Lateral Sclerosis
SourceMarket Overview
Stock performance and key metrics
Linagliptin
Diabetes Mellitus, Type 2
MN-166
Glioblastoma
ibudilast
Amyotrophic Lateral Sclerosis
MN-221
Asthma
MN-001 BID
Interstitial Cystitis
riluzole
Amyotrophic Lateral Sclerosis
MN-166 First
Opioid Abuse
MN-001
Non-alcoholic Steatohepatitis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Linagliptin | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
MN-166 | Phase 3 | Glioblastoma | - | - |
ibudilast | Phase 2 | Amyotrophic Lateral Sclerosis | - | - |
MN-221 | Phase 2 | Asthma | - | - |
MN-001 BID | Phase 2 | Interstitial Cystitis | - | - |
riluzole | Phase 2 | Amyotrophic Lateral Sclerosis | - | - |
MN-166 First | Phase 2 | Opioid Abuse | - | - |
MN-001 | Phase 2 | Non-alcoholic Steatohepatitis | - | - |
Frequently asked questions
What is in MediciNova, Inc.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in MediciNova, Inc.'s (MNOV) pipeline across Phase 3, Phase 2. Its lead program is MN-166 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MediciNova, Inc.'s next FDA catalyst?→
MediciNova, Inc.'s (MNOV) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MNOV biotech catalysts?→
Add MNOV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MediciNova, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.